These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30111221)

  • 1. Enhancement of anti-tumor effect of plasmid DNA-carrying MUC1 by the adjuvanticity of FLT3L in mouse model.
    Gao FS; Zhan YT; Wang XD; Zhang C
    Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):353-357. PubMed ID: 30111221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced synergistic anti-Lewis lung carcinoma effect of a DNA vaccine harboring a MUC1-VEGFR2 fusion gene used with GM-CSF as an adjuvant.
    Ruan J; Duan Y; Li F; Wang Z
    Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):71-78. PubMed ID: 27562635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats.
    Zhang S; Zhang H; Shi H; Yu X; Kong W; Li W
    Hum Immunol; 2008; 69(4-5):250-8. PubMed ID: 18486759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
    Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
    Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC1- and Survivin-based DNA Vaccine Combining Immunoadjuvants CpG and interleukin-2 in a Bicistronic Expression Plasmid Generates Specific Immune Responses and Antitumour Effects in a Murine Colorectal Carcinoma Model.
    Liu C; Xie Y; Sun B; Geng F; Zhang F; Guo Q; Wu H; Yu B; Wu J; Yu X; Kong W; Zhang H
    Scand J Immunol; 2018 Feb; 87(2):63-72. PubMed ID: 29193199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model.
    Zhang H; Liu C; Zhang F; Geng F; Xia Q; Lu Z; Xu P; Xie Y; Wu H; Yu B; Wu J; Yu X; Kong W
    Vaccine; 2016 May; 34(24):2648-55. PubMed ID: 27113167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell Responses.
    Thorne AH; Malo KN; Wong AJ; Nguyen TT; Cooch N; Reed C; Yan J; Broderick KE; Smith TRF; Masteller EL; Humeau L
    Front Immunol; 2020; 11():327. PubMed ID: 32161596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice.
    Snyder LA; Goletz TJ; Gunn GR; Shi FF; Harris MC; Cochlin K; McCauley C; McCarthy SG; Branigan PJ; Knight DM
    Vaccine; 2006 Apr; 24(16):3340-52. PubMed ID: 16472547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.
    Yo YT; Hsu KF; Shieh GS; Lo CW; Chang CC; Wu CL; Shiau AL
    Cancer Gene Ther; 2007 Nov; 14(11):904-17. PubMed ID: 17704754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of DNA vaccination against botulinum neurotoxin serotype A by co-administration of plasmids encoding DC-stimulating Flt3L and MIP-3α cytokines.
    Xu Q; Zhu YF; Wang HC; Gong ZW; Yu YZ
    Biologicals; 2016 Sep; 44(5):441-7. PubMed ID: 27430905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The increasingly anti-tumor effect of a colonic carcinoma DNA vaccine carrying HER2 by the adjuvanticity of IL-12.
    Gao P; Zhang C; Bian X; Guo Y; Wei Y; Zhang L; Liu Z; Wang X; Huang S
    Immunopharmacol Immunotoxicol; 2016 Dec; 38(6):441-446. PubMed ID: 27660891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model.
    Kontani K; Taguchi O; Ozaki Y; Hanaoka J; Tezuka N; Sawai S; Inoue S; Fujino S; Maeda T; Itoh Y; Ogasawara K; Sato H; Ohkubo I; Kudo T
    Cancer Gene Ther; 2002 Apr; 9(4):330-7. PubMed ID: 11960283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine.
    Gableh F; Saeidi M; Hemati S; Hamdi K; Soleimanjahi H; Gorji A; Ghaemi A
    J Biomed Sci; 2016 Jan; 23():16. PubMed ID: 26811064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant.
    Zhou Q; Wang F; Yang F; Wang Y; Zhang X; Sun S
    Vaccine; 2010 Feb; 28(5):1357-62. PubMed ID: 19932674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity.
    Sang H; Pisarev VM; Munger C; Robinson S; Chavez J; Hatcher L; Parajuli P; Guo Y; Talmadge JE
    Vaccine; 2003 Jun; 21(21-22):3019-29. PubMed ID: 12798646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect.
    Liu C; Lu Z; Xie Y; Guo Q; Geng F; Sun B; Wu H; Yu B; Wu J; Zhang H; Yu X; Kong W
    Immunol Lett; 2018 Aug; 200():33-42. PubMed ID: 29894719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies.
    Le Pogam C; Patel S; Gorombei P; Guerenne L; Krief P; Omidvar N; Tekin N; Bernasconi E; Sicre F; Schlageter MH; Chopin M; Noguera ME; West R; Abu A; Mathews V; Pla M; Fenaux P; Chomienne C; Padua RA
    Oncotarget; 2015 Oct; 6(32):32494-508. PubMed ID: 26378812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of the soluble isoform of hFlt3 ligand by recombinant vaccinia virus enhances immunogenicity of the vector.
    Zurkova K; Babiarova K; Hainz P; Krystofova J; Kutinova L; Otahal P; Nemeckova S
    Oncol Rep; 2009 May; 21(5):1335-43. PubMed ID: 19360312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.